Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 141625-93-6
2. Dronedarone Hcl
3. N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)benzofuran-5-yl)methanesulfonamide Hydrochloride
4. Dronedarone, Hcl
5. Dronedarone (hydrochloride)
6. Dronedarone Hydrochloride [usan]
7. Sr33598b
8. Sr33589 Hydrochloride
9. Dronedarone Hcl (multaq)
10. Fa36dv299q
11. N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-1-benzofuran-5-yl]methanesulfonamide;hydrochloride
12. Sr-33598b
13. 141625-93-6 (hcl); 141626-36-0 (free Base).
14. Methanesulfonamide, N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-, Monohydrochloride
15. N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-benzofuran-5-yl)methanesulfonamide Hydrochloride
16. N-(2-butyl-3-(4-(3-(dibutylamino)proproxy)benzoyl)benzofuran-5-yl) Methanesulfonamide-, Monohydrochloride
17. N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]methanesulfonamide Hydrochloride
18. Smr003500707
19. Unii-fa36dv299q
20. Dronedarone Hcl
21. Mfcd00914940
22. Multaq (tn)
23. N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide Monohydrochloride
24. Dronedarone Hydrocholoride
25. 4ch-007232
26. Mls004774028
27. Mls006011986
28. Schembl223035
29. Chembl1201729
30. Dronedarone Hydrochloride (usp)
31. Dronedarone Hydrochloride- Bio-x
32. Dtxsid30161779
33. Bcp22474
34. S2114
35. Dronedarone Hydrochloride [mi]
36. Akos005145691
37. Ac-5011
38. Ccg-270168
39. Cs-0712
40. Ks-1260
41. Dronedarone Hydrochloride [mart.]
42. Bd164395
43. Dronedarone Hydrochloride [usp-rs]
44. Dronedarone Hydrochloride [who-dd]
45. Hy-75839
46. N-(2-butyl-3-{4-[3-(dibutylamino)propoxy]benzoyl}-1-benzofuran-5-yl)methanesulfonamide Hydrochloride
47. Dronedarone Hydrochloride, >=98% (hplc)
48. D4689
49. Ft-0667799
50. Sw219413-1
51. D03914
52. Dronedarone Hydrochloride [ep Monograph]
53. Dronedarone Hydrochloride [orange Book]
54. Dronedarone Hydrochloride [usp Monograph]
55. A807785
56. J-007525
57. J-520429
58. Q27277877
59. Z1550675452
60. Dronedarone Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
61. Dronedarone Hydrochloride, United States Pharmacopeia (usp) Reference Standard
62. N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]benzofuran-5-yl]methanesulfonamide Hcl
63. 2-n-butyl 3-[4-(3-di-n-butylamino-propoxy)benzoyl] 5-methylsulfonamido Benzofuran Hydrochloride
64. Methanesulfonamide, N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]-, Hydrochloride (1:1)
Molecular Weight | 593.2 g/mol |
---|---|
Molecular Formula | C31H45ClN2O5S |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 18 |
Exact Mass | 592.2737714 g/mol |
Monoisotopic Mass | 592.2737714 g/mol |
Topological Polar Surface Area | 97.2 Ų |
Heavy Atom Count | 40 |
Formal Charge | 0 |
Complexity | 800 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
26
PharmaCompass offers a list of Dronedarone Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dronedarone Hydrochloride manufacturer or Dronedarone Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dronedarone Hydrochloride manufacturer or Dronedarone Hydrochloride supplier.
PharmaCompass also assists you with knowing the Dronedarone Hydrochloride API Price utilized in the formulation of products. Dronedarone Hydrochloride API Price is not always fixed or binding as the Dronedarone Hydrochloride Price is obtained through a variety of data sources. The Dronedarone Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A J-520429 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of J-520429, including repackagers and relabelers. The FDA regulates J-520429 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. J-520429 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of J-520429 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A J-520429 supplier is an individual or a company that provides J-520429 active pharmaceutical ingredient (API) or J-520429 finished formulations upon request. The J-520429 suppliers may include J-520429 API manufacturers, exporters, distributors and traders.
click here to find a list of J-520429 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A J-520429 DMF (Drug Master File) is a document detailing the whole manufacturing process of J-520429 active pharmaceutical ingredient (API) in detail. Different forms of J-520429 DMFs exist exist since differing nations have different regulations, such as J-520429 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A J-520429 DMF submitted to regulatory agencies in the US is known as a USDMF. J-520429 USDMF includes data on J-520429's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The J-520429 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of J-520429 suppliers with USDMF on PharmaCompass.
A J-520429 CEP of the European Pharmacopoeia monograph is often referred to as a J-520429 Certificate of Suitability (COS). The purpose of a J-520429 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of J-520429 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of J-520429 to their clients by showing that a J-520429 CEP has been issued for it. The manufacturer submits a J-520429 CEP (COS) as part of the market authorization procedure, and it takes on the role of a J-520429 CEP holder for the record. Additionally, the data presented in the J-520429 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the J-520429 DMF.
A J-520429 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. J-520429 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of J-520429 suppliers with CEP (COS) on PharmaCompass.
A J-520429 written confirmation (J-520429 WC) is an official document issued by a regulatory agency to a J-520429 manufacturer, verifying that the manufacturing facility of a J-520429 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting J-520429 APIs or J-520429 finished pharmaceutical products to another nation, regulatory agencies frequently require a J-520429 WC (written confirmation) as part of the regulatory process.
click here to find a list of J-520429 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing J-520429 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for J-520429 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture J-520429 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain J-520429 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a J-520429 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of J-520429 suppliers with NDC on PharmaCompass.
J-520429 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of J-520429 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right J-520429 GMP manufacturer or J-520429 GMP API supplier for your needs.
A J-520429 CoA (Certificate of Analysis) is a formal document that attests to J-520429's compliance with J-520429 specifications and serves as a tool for batch-level quality control.
J-520429 CoA mostly includes findings from lab analyses of a specific batch. For each J-520429 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
J-520429 may be tested according to a variety of international standards, such as European Pharmacopoeia (J-520429 EP), J-520429 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (J-520429 USP).